Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Adverum Biotechnologies, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 71 | 1 | 59 | −11 |
| Shares | 16.3M | 160.2K | 14.0M | −2.17M (−13.4%) |
| Value | $69.8M | $461.3K | $30.1M | −$39.2M (−56.6%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 342,340 | $736.0K | 0.00% |
| Citadel Advisors LLC | 78,271 | $168.3K | 0.00% |
| Jane Street Group, LLC | 70,931 | $152.5K | 0.00% |
| Readystate Asset Management LP | 67,602 | $145.3K | 0.01% |
| Marshall Wace, LLP | 49,628 | $106.7K | 0.00% |
| Qube Research & Technologies Ltd | 30,679 | $66.0K | 0.00% |
| HRT Financial LP | 30,627 | $65.0K | 0.00% |
| XTX Topco Ltd | 29,755 | $64.0K | 0.00% |
| Jain Global LLC | 21,819 | $46.9K | 0.00% |
| Squarepoint Ops LLC | 21,652 | $46.6K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 21,122 | $45.4K | 0.00% |
| Two Sigma Investments, LP | 18,757 | $40.3K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 14,582 | $31.4K | 0.01% |
| Two Sigma Advisers, LP | 10,681 | $23.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 1,916 | $4.12K | 0.00% |
| Jones Financial Companies LLLP | 1,000 | $2.32K | 0.00% |
| Raymond James Financial Inc | 1,000 | $2.15K | 0.00% |
| Point72 (DIFC) Ltd | 225 | $484 | 0.00% |
Sold out (29)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
Not filed for Q2 2025 yet (1)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Grant/GrossMendelsohn, LLC | 160,157 | $461.3K |